Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001
Prevalence and clinical relevance of comorbidities in IPF Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018
Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease Source: ERJ Open Res, 7 (3) 00068-2021; 10.1183/23120541.00068-2021 Year: 2021
Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma Source: Eur Respir J 2006; 28: Suppl. 50, 122s Year: 2006
Correlation of clinical, laboratory and functional parameters in stable chronic obstructive pulmonary disease Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014
Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label Source: Eur Respir J, 51 (1) 1701817; 10.1183/13993003.01817-2017 Year: 2018
Hepatic function markers in COPD as a systemic implication of the disease Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008
SW13,15,17 Clinical, radiological and pathological correlations in lung diseases Source: Milan 2017 - Educational material Year: 2017
COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011
Structural and biochemical characteristics of subclinical atherosclerosis in COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010
Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020
Clinical features and outcomes of patients with myositis associated-interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021
Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020
Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity Source: International Congress 2015 – Interstitial lung diseases II Year: 2015
Clinical effectiveness of steroid treatment on lung function and immunologic markers in pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 86s Year: 2007
The subclinical atherosclerosis and its association to clinical features of stable COPD Source: Annual Congress 2011 - COPD management Year: 2011
Biomarkers of airways inflammation in patients with severe asthma in a real clinical practice Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019
Markers of early disease and prognosis in COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009
Evaluation of metabolic profile in patients with chronic obstructive pulmonary disease and correlation between the metabolic parameters and the severity of disease Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006